Omega-3 Phospholipid Supplement Reduces Brain Damage in Newborn Mice After Oxygen Deprivation

This study looked at a lysophosphatidylcholine-bound omega-3 (LPC-omega-3) supplement called Lysoveta, which is designed to be absorbed into the brain more efficiently than standard fish oil forms. Researchers tested it in newborn mice that experienced a hypoxic-ischemic (oxygen-deprivation) brain injury, a model used to study conditions similar to birth asphyxia in infants.

Mice received oral Lysoveta for seven days after the injury, either alone or combined with stem cell therapy delivered through the nose. Several weeks later, the researchers measured behavior (memory, movement, exploration) and examined brain tissue for gray and white matter damage.

Lysoveta reduced physical brain tissue damage in both gray matter and the myelin-related white matter, and it protected nerve cells from oxidative stress in lab dish experiments. However, it did not improve the behavioral or functional outcomes measured in the mice, and it did not add any extra benefit when combined with stem cell therapy.